首页> 外文OA文献 >Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology

【2h】

Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology

机译：敏感的分子试验方法可以证明恶性胸腔积液中的NSCLC驱动突变，尽管是非恶性细胞学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Daniel P. Steinfort; Sevastjan Kranz; Anthony Dowers; Leakhena Leas; Voula Dimitriadis; Kym Pham; Arthur Hsu; Steven Bozinovski; Louis B. Irving; Paula Loveland; Michael Christie;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing [J] . YeoC.D., KimJ.W., KimK.H., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2013,第2期

机译：通过PNA钳夹和直接测序检测和比较NSCLC恶性胸腔积液患者的匹配肿瘤组织，细胞块，胸腔积液和血清中的EGFR突变
2. Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions [J] . P Korczynski, R Krenke, A Safianowska, European journal of medical research. . 2009,第Suppla4期

机译：胸膜液和血清标志物在恶性和非恶性胸腔积液的差异中的诊断效用
3. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples [J] . Yinying Zou, Liming Xu, Qiusu Tang, BMC Cancer . 2020,第1期

机译：来自恶性胸腔积液的细胞学细胞嵌段是高级NSCLC中PD-L1检测的良好候选者与匹配的组织学样品相比
4. Intra-pleural Cavity hot Saline Perfusion and Intra-pleural Cavity cis-DDPInjection in the Treatment of malignant Pleural Effusion,the Preliminary Observation [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：胸腔内热盐水灌注和胸腔内顺式-DDP注射液治疗恶性胸腔积液的初步观察
5. Dolo?anje Mutacij v Genih BRCA1/2 Iz citolo?kega Materiala Pri Raku jaj?nikov, Jajcevodov in Primarnem Peritonealnem Seroznem Karcinomu =BRCA1/2 mutation testing from cytological samples in patients with ovarian, tubal and primary peritoneal serous cancer [D] . Gornjec, Andreja. 2020

机译：从自我癌症中确定基因Krca1 / 2中的突变吗？
6. Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology [O] . Daniel P. Steinfort, Sevastjan Kranz, Anthony Dowers, 2019

机译：尽管细胞学检查为非恶性但敏感的分子检测方法仍可证明恶性胸腔积液中的NSCLC驱动程序突变
7. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples [O] . Yinying Zou, Liming Xu, Qiusu Tang, 2020

机译：来自恶性胸腔积液的细胞学细胞嵌段是高级NSCLC中PD-L1检测的良好候选者与匹配的组织学样品相比

Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology

著录项

引文网络

相似文献

相关主题

期刊订阅